换一批
换一批Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
作者：
主题词
老年人(Aged);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);苯咪唑类(Benzimidazoles);苯甲酸盐类(Benzoates);心血管疾病(Cardiovascular Diseases);糖尿病(Diabetes Mellitus);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);中年人(Middle Aged);病人遴选(Patient Selection);雷米普利(Ramipril);随机对照试验(主题)(Randomized Controlled Trials as Topic);研究设计(Research Design)
DOI
10.1016/j.ahj.2004.03.020
PMID
15215792
发布时间
2018-11-30
- 浏览55
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
